MA26594A1 - NOVEL MMP INHIBITOR COMPOUNDS, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM - Google Patents
NOVEL MMP INHIBITOR COMPOUNDS, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEMInfo
- Publication number
- MA26594A1 MA26594A1 MA25419A MA25419A MA26594A1 MA 26594 A1 MA26594 A1 MA 26594A1 MA 25419 A MA25419 A MA 25419A MA 25419 A MA25419 A MA 25419A MA 26594 A1 MA26594 A1 MA 26594A1
- Authority
- MA
- Morocco
- Prior art keywords
- preparation
- pharmaceutical compositions
- compositions containing
- inhibitor compounds
- mmp inhibitor
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/72—Nitrogen atoms
- C07D213/75—Amino or imino radicals, acylated by carboxylic or carbonic acids, or by sulfur or nitrogen analogues thereof, e.g. carbamates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
- C07C237/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton
- C07C237/22—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton having nitrogen atoms of amino groups bound to the carbon skeleton of the acid part, further acylated
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C259/00—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups
- C07C259/04—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups without replacement of the other oxygen atom of the carboxyl group, e.g. hydroxamic acids
- C07C259/06—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups without replacement of the other oxygen atom of the carboxyl group, e.g. hydroxamic acids having carbon atoms of hydroxamic groups bound to hydrogen atoms or to acyclic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C259/00—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups
- C07C259/12—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups with replacement of the other oxygen atom of the carboxyl group by nitrogen atoms, e.g. N-hydroxyamidines
- C07C259/18—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups with replacement of the other oxygen atom of the carboxyl group by nitrogen atoms, e.g. N-hydroxyamidines having carbon atoms of hydroxamidine groups bound to carbon atoms of six-membered aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
- C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
- C07D317/10—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings
- C07D317/32—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D317/34—Oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/07—Optical isomers
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2602/00—Systems containing two condensed rings
- C07C2602/02—Systems containing two condensed rings the rings having only two atoms in common
- C07C2602/04—One of the condensed rings being a six-membered aromatic ring
- C07C2602/08—One of the condensed rings being a six-membered aromatic ring the other ring being five-membered, e.g. indane
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Physical Education & Sports Medicine (AREA)
- Rheumatology (AREA)
- Reproductive Health (AREA)
- Dermatology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Immunology (AREA)
- Heart & Thoracic Surgery (AREA)
- Urology & Nephrology (AREA)
- Oncology (AREA)
- Cardiology (AREA)
- Vascular Medicine (AREA)
- Gynecology & Obstetrics (AREA)
- Pregnancy & Childbirth (AREA)
- Pain & Pain Management (AREA)
- Endocrinology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pyridine Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB9800510.1A GB9800510D0 (en) | 1998-01-09 | 1998-01-09 | Therapeutic agents |
GBGB9811843.3A GB9811843D0 (en) | 1998-06-02 | 1998-06-02 | Therapeutic agents |
Publications (1)
Publication Number | Publication Date |
---|---|
MA26594A1 true MA26594A1 (en) | 2004-12-20 |
Family
ID=26312925
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MA25419A MA26594A1 (en) | 1998-01-09 | 1999-01-06 | NOVEL MMP INHIBITOR COMPOUNDS, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM |
Country Status (37)
Country | Link |
---|---|
US (1) | US6350907B1 (en) |
EP (1) | EP1047665B1 (en) |
JP (1) | JP3621884B2 (en) |
KR (1) | KR100385662B1 (en) |
CN (1) | CN1284942A (en) |
AP (1) | AP1059A (en) |
AR (1) | AR014270A1 (en) |
AT (1) | ATE252547T1 (en) |
AU (1) | AU736511B2 (en) |
BG (1) | BG104575A (en) |
BR (1) | BR9813719A (en) |
CA (1) | CA2317604C (en) |
CO (1) | CO4990971A1 (en) |
CZ (1) | CZ20002459A3 (en) |
DE (1) | DE69819206T2 (en) |
DK (1) | DK1047665T3 (en) |
DZ (1) | DZ2701A1 (en) |
EA (1) | EA002971B1 (en) |
ES (1) | ES2209244T3 (en) |
HN (1) | HN1998000199A (en) |
HR (1) | HRP20000460A2 (en) |
HU (1) | HUP0101300A3 (en) |
IL (1) | IL136889A0 (en) |
IS (1) | IS5531A (en) |
MA (1) | MA26594A1 (en) |
NO (1) | NO20003506D0 (en) |
NZ (1) | NZ504683A (en) |
OA (1) | OA11435A (en) |
PA (1) | PA8466101A1 (en) |
PE (1) | PE20000176A1 (en) |
PL (1) | PL342763A1 (en) |
PT (1) | PT1047665E (en) |
SI (1) | SI1047665T1 (en) |
SK (1) | SK10112000A3 (en) |
TN (1) | TNSN99002A1 (en) |
TR (1) | TR200001909T2 (en) |
WO (1) | WO1999035124A1 (en) |
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE69905397T2 (en) * | 1998-12-31 | 2003-12-18 | Aventis Pharmaceuticals Inc., Bridgewater | SELECTIVE INHIBITORS OF THE MMP-12 |
US6352976B1 (en) | 1998-12-31 | 2002-03-05 | Aventis Pharmaceuticals Inc. | Selective inhibitors of MMP-12 |
JP2001055327A (en) * | 1999-06-11 | 2001-02-27 | Fuji Chemical Industries Ltd | New medicine containing hydroxamic acid derivative |
GB0025310D0 (en) * | 2000-10-16 | 2000-11-29 | Pfizer Ltd | Process |
US6452041B1 (en) | 2000-10-16 | 2002-09-17 | Pfizer Inc. | Olefination process to itaconate and succinate derivatives |
ATE327986T1 (en) * | 2001-02-16 | 2006-06-15 | Allelix Neuroscience Inc | THIOPHENE SUBSTITUTED AMINE DERIVATIVES AS GLYT-1 INHIBITORS |
GB0126389D0 (en) * | 2001-11-02 | 2002-01-02 | Pfizer Ltd | Wafer |
PA8578101A1 (en) * | 2002-08-13 | 2004-05-07 | Warner Lambert Co | HETEROBIARILO DERIVATIVES AS METALOPROTEINASE IN MATRIX INHIBITORS |
US20040138103A1 (en) * | 2002-11-07 | 2004-07-15 | Procyte Corporation | Compositions containing peptide copper complexes and metalloproteinase inhibitors and methods related thereto |
EP1594459B1 (en) | 2002-12-30 | 2010-02-17 | Angiotech International Ag | Drug delivery from rapid gelling polymer composition |
KR20060037446A (en) * | 2003-08-23 | 2006-05-03 | 베르날리스(옥스포드)엘티디 | Derivatives of hydroxamic acid as metalloproteinase inhibitors |
CA2663730A1 (en) * | 2006-09-29 | 2008-04-03 | F. Hoffmann-La Roche Ag | Assessing the risk of disease progression for a patient with rheumatoid arthritis |
CN104788333B (en) * | 2015-03-19 | 2017-03-22 | 中国医科大学 | 2-substituted-9,10-anthraquinone compounds, and preparation method and application thereof |
Family Cites Families (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5892112A (en) | 1990-11-21 | 1999-04-06 | Glycomed Incorporated | Process for preparing synthetic matrix metalloprotease inhibitors |
GB9215665D0 (en) | 1992-07-23 | 1992-09-09 | British Bio Technology | Compounds |
JPH08503475A (en) | 1992-11-25 | 1996-04-16 | メルク エンド カンパニー インコーポレーテッド | Carboxy-peptidyl derivatives as anti-modifying activators |
AU6575394A (en) | 1993-04-27 | 1994-11-21 | Celltech Therapeutics Limited | Peptidyl derivatives as metalloproteinase inhibitors |
GB9308695D0 (en) | 1993-04-27 | 1993-06-09 | Celltech Ltd | Peptidyl derivatives |
GB9320660D0 (en) | 1993-10-07 | 1993-11-24 | British Bio Technology | Inhibition of cytokine production |
US6037472A (en) * | 1993-11-04 | 2000-03-14 | Syntex (U.S.A.) Inc. | Matrix metalloprotease inhibitors |
UA48121C2 (en) | 1993-11-04 | 2002-08-15 | Сінтекс (С.Ш.А.) Інк. | Inhibitors of matrix metalloproteases and pharmaceutical composition on their basis |
DE69515702T2 (en) | 1994-01-20 | 2000-08-10 | British Biotech Pharmaceuticals Ltd., Cowley | L-tertiary leucine-2-pyridylamide |
AU678884B2 (en) | 1994-01-22 | 1997-06-12 | British Biotech Pharmaceuticals Limited | Metalloproteinase inhibitors |
WO1995032944A1 (en) | 1994-05-28 | 1995-12-07 | British Biotech Pharmaceuticals Limited | Succinyl hydroxamic acid, n-formyl-n-hydroxy amino carboxylic acid and succinic acid amide derivatives as metalloprotease inhibitors |
US5461746A (en) * | 1995-01-17 | 1995-10-31 | Tdw Delaware, Inc. | Magnetic cleaning pig |
US5691381A (en) | 1995-04-18 | 1997-11-25 | The Dupont Merck Pharmaceutical Company | Hydroxamic and carbocyclic acids as metalloprotease inhibitors |
GB9507799D0 (en) * | 1995-04-18 | 1995-05-31 | British Biotech Pharm | Metalloproteinase inhibitors |
US5994293A (en) | 1995-05-10 | 1999-11-30 | Darwin Discovery Ltd. | Peptidyl compounds and their therapeutic use |
JPH11504646A (en) | 1995-05-10 | 1999-04-27 | カイロサイエンス・リミテッド | Peptide compounds inhibiting the release of metalloproteases and TNF and their therapeutic use |
GB9513331D0 (en) | 1995-06-30 | 1995-09-06 | British Biotech Pharm | Matrix metalloproteinase inhibitors |
US5917090A (en) * | 1995-06-30 | 1999-06-29 | British Biotech Pharmaceuticals Ltd. | Matrix metalloproteinase inhibitors |
US5840974A (en) * | 1996-12-04 | 1998-11-24 | Britisch Biotech Pharmaceuticals, Ltd. | Metalloproteinase inhibitors |
-
1998
- 1998-12-23 HU HU0101300A patent/HUP0101300A3/en unknown
- 1998-12-23 DK DK98966429T patent/DK1047665T3/en active
- 1998-12-23 AU AU22776/99A patent/AU736511B2/en not_active Ceased
- 1998-12-23 PL PL98342763A patent/PL342763A1/en unknown
- 1998-12-23 BR BR9813719-0A patent/BR9813719A/en not_active Application Discontinuation
- 1998-12-23 KR KR10-2000-7007583A patent/KR100385662B1/en not_active IP Right Cessation
- 1998-12-23 DE DE69819206T patent/DE69819206T2/en not_active Expired - Fee Related
- 1998-12-23 JP JP2000527526A patent/JP3621884B2/en not_active Expired - Fee Related
- 1998-12-23 EA EA200000628A patent/EA002971B1/en not_active IP Right Cessation
- 1998-12-23 NZ NZ504683A patent/NZ504683A/en unknown
- 1998-12-23 PT PT98966429T patent/PT1047665E/en unknown
- 1998-12-23 CA CA002317604A patent/CA2317604C/en not_active Expired - Fee Related
- 1998-12-23 EP EP98966429A patent/EP1047665B1/en not_active Expired - Lifetime
- 1998-12-23 AT AT98966429T patent/ATE252547T1/en not_active IP Right Cessation
- 1998-12-23 ES ES98966429T patent/ES2209244T3/en not_active Expired - Lifetime
- 1998-12-23 SI SI9830577T patent/SI1047665T1/en unknown
- 1998-12-23 SK SK1011-2000A patent/SK10112000A3/en unknown
- 1998-12-23 CN CN98812936A patent/CN1284942A/en active Pending
- 1998-12-23 CZ CZ20002459A patent/CZ20002459A3/en unknown
- 1998-12-23 IL IL13688998A patent/IL136889A0/en unknown
- 1998-12-23 WO PCT/EP1998/008565 patent/WO1999035124A1/en active IP Right Grant
- 1998-12-23 TR TR2000/01909T patent/TR200001909T2/en unknown
- 1998-12-30 CO CO98077587A patent/CO4990971A1/en unknown
- 1998-12-30 HN HN1998000199A patent/HN1998000199A/en unknown
-
1999
- 1999-01-04 PE PE1999000004A patent/PE20000176A1/en not_active Application Discontinuation
- 1999-01-04 PA PA19998466101A patent/PA8466101A1/en unknown
- 1999-01-06 MA MA25419A patent/MA26594A1/en unknown
- 1999-01-06 TN TNTNSN99002A patent/TNSN99002A1/en unknown
- 1999-01-06 DZ DZ990002A patent/DZ2701A1/en active
- 1999-01-07 AR ARP990100048A patent/AR014270A1/en not_active Application Discontinuation
- 1999-01-07 AP APAP/P/1999/001436A patent/AP1059A/en active
-
2000
- 2000-04-11 US US09/546,756 patent/US6350907B1/en not_active Expired - Fee Related
- 2000-06-13 IS IS5531A patent/IS5531A/en unknown
- 2000-06-23 OA OA1200000188A patent/OA11435A/en unknown
- 2000-07-04 BG BG104575A patent/BG104575A/en unknown
- 2000-07-07 HR HR20000460A patent/HRP20000460A2/en not_active Application Discontinuation
- 2000-07-07 NO NO20003506A patent/NO20003506D0/en not_active Application Discontinuation
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
FR2780057B1 (en) | PHENOXYPROPANOLAMINES, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | |
MA26687A1 (en) | 4-CARBOXYAMINO-2-METHYL-1,2,3,4-TETRAHYDROQUINOLEINES, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | |
MA26743A1 (en) | NEW METALLOPROTEASE INHIBITOR COMPOUNDS, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | |
MA26686A1 (en) | NOVEL 4,4-BIARYLPIPERIDINE DERIVATIVES, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | |
MA26622A1 (en) | NOVEL PYRAZOLOPYRIMIDINONES, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | |
MA26638A1 (en) | NOVEL ISOTHIAZOLE DERIVATIVES, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | |
MA26680A1 (en) | NEW ALCYNYL SUBSTITUTE QUINOLEIN-2-ONE DERIVATIVES, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | |
MA26630A1 (en) | NOVEL 4-PHENYLPYPERIDINES, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | |
MA26620A1 (en) | NEW BICYCLIC HYDROXAMIC ACID DERIVATIVES, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | |
FR2729951B1 (en) | NOVEL HETEROCYCLIC COMPOUNDS, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME | |
MA26611A1 (en) | NOVEL HETEROCYCLIC COMPOUNDS INHIBITORS OF ROMATASES, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | |
MA26730A1 (en) | NOVEL NPY ANTAGONIST COMPOUNDS, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | |
MA26654A1 (en) | NEW PYRROLOPYRIMIDINES PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | |
MA26675A1 (en) | NOVEL HYDROXYPIPECOLATE-HYDROXAMIC ACID DERIVATIVES, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | |
DZ2745A1 (en) | Novel bicycloÄ2.2.1Üheptanes for their preparation and pharmaceutical compositions containing them. | |
MA24832A1 (en) | ACID HYDROXAMIDES (4-ARYLSULFONYLAMINO) -TETRAHYDROPYRANNE-4-CARBOXYLIQUES), PROCESS FOR THEIR PREPARATION AND COMPOSITIONS CONTAINING THEM | |
MA26624A1 (en) | NEW QUINAZOLINAMINE DERIVATIVES, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | |
MA26740A1 (en) | NOVEL 13-METHYL-ERYTHROMYCIN DERIVATIVES, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | |
MA26433A1 (en) | PYRIDYLPYRROLE DERIVATIVES, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | |
MA26465A1 (en) | NEW QUINOLEIN DERIVATIVES AND QUINAZOLINE DERIVATIVES, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | |
MA26558A1 (en) | NOVEL 6-0-METHYLERYTHROMYCIN A DERIVATIVES, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM. | |
FR2794742B1 (en) | NOVEL BENZENE DERIVATIVES, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING SAME | |
MA26707A1 (en) | NOVEL AZALIDES, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM. | |
MA26501A1 (en) | NEW QUINOLEIN DERIVATIVES, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | |
DZ2751A1 (en) | New calciolytic compounds process for their preparation and pharmaceutical compositions containing them. |